Article Information
History
- February 9, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 9, 2021 - 03:36).
- Version 2 (April 17, 2021 - 15:12).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marie I. Samanovic1,#,
- Amber R. Cornelius1,#,
- Jimmy P. Wilson1,
- Trishala Karmacharya1,
- Sophie L. Gray-Gaillard1,
- Joseph Richard Allen1,
- Sara Wesley Hyman1,
- Gali Moritz1,
- Mahnoor Ali1,
- Sergei B. Koralov2,
- Mark J. Mulligan1,#,* and
- Ramin Sedaghat Herati1,#,*
- 1NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY
- 2Department of Pathology, New York University School of Medicine, New York, NY
- ↵*Correspondence/Reprint Requests: Ramin Sedaghat Herati, Department of Medicine, Division of Infectious Diseases and Immunology NYU Langone School of Medicine, 430 E. 29th St, Alexandria Center for Life Sciences West, New York, NY 10016, Email: ramin.herati{at}nyulangone.org, Mark J. Mulligan, Department of Medicine, Division of Infectious Diseases and Immunology NYU Langone School of Medicine, 430 E. 29th St, Alexandria Center for Life Sciences West, New York, NY 10016 Email: mark.mulligan{at}nyulangone.org
↵# These authors contributed equally.
δ These authors contributed equally.